157 related articles for article (PubMed ID: 25721210)
1. Infiltration of dendritic cells and T lymphocytes predicts favorable outcome in epithelial ovarian cancer.
Zhang Z; Huang J; Zhang C; Yang H; Qiu H; Li J; Liu Y; Qin L; Wang L; Hao S; Zhang F; Wang X; Shan B
Cancer Gene Ther; 2015 Mar; 22(4):198-206. PubMed ID: 25721210
[TBL] [Abstract][Full Text] [Related]
2. Tumor-infiltrating cytotoxic T lymphocytes as independent prognostic factor in epithelial ovarian cancer with wilms tumor protein 1 overexpression.
Vermeij R; de Bock GH; Leffers N; Ten Hoor KA; Schulze U; Hollema H; van der Burg SH; van der Zee AG; Daemen T; Nijman HW
J Immunother; 2011; 34(6):516-23. PubMed ID: 21654520
[TBL] [Abstract][Full Text] [Related]
3. Higher Numbers of T-Bet+ Tumor-Infiltrating Lymphocytes Associate with Better Survival in Human Epithelial Ovarian Cancer.
Xu Y; Chen L; Xu B; Xiong Y; Yang M; Rui X; Shi L; Wu C; Jiang J; Lu B
Cell Physiol Biochem; 2017; 41(2):475-483. PubMed ID: 28214872
[TBL] [Abstract][Full Text] [Related]
4. Multivariate analysis by Cox proportional hazard model on prognosis of patient with epithelial ovarian cancer.
Wang M; He Y; Shi L; Shi C
Eur J Gynaecol Oncol; 2011; 32(2):171-7. PubMed ID: 21614907
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer.
Lundgren S; Berntsson J; Nodin B; Micke P; Jirström K
J Ovarian Res; 2016 Apr; 9():21. PubMed ID: 27048364
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients--a study of the OVCAD consortium.
Bachmayr-Heyda A; Aust S; Heinze G; Polterauer S; Grimm C; Braicu EI; Sehouli J; Lambrechts S; Vergote I; Mahner S; Pils D; Schuster E; Thalhammer T; Horvat R; Denkert C; Zeillinger R; Castillo-Tong DC
BMC Cancer; 2013 Sep; 13():422. PubMed ID: 24044611
[TBL] [Abstract][Full Text] [Related]
7. Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients.
Truxova I; Kasikova L; Hensler M; Skapa P; Laco J; Pecen L; Belicova L; Praznovec I; Halaska MJ; Brtnicky T; Salkova E; Rob L; Kodet R; Goc J; Sautes-Fridman C; Fridman WH; Ryska A; Galluzzi L; Spisek R; Fucikova J
J Immunother Cancer; 2018 Dec; 6(1):139. PubMed ID: 30526667
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.
Zhang J; Tang L; Chen Y; Duan Z; Xiao L; Li W; Liu X; Shen L
Hum Pathol; 2015 Sep; 46(9):1331-40. PubMed ID: 26193797
[TBL] [Abstract][Full Text] [Related]
9. Do tumor-infiltrating lymphocytes really indicate favorable prognosis in epithelial ovarian cancer?
Yildirim N; Akman L; Acar K; Demir S; Ozkan S; Alan N; Zekioglu O; Terek MC; Ozdemir N; Ozsaran A
Eur J Obstet Gynecol Reprod Biol; 2017 Aug; 215():55-61. PubMed ID: 28601728
[TBL] [Abstract][Full Text] [Related]
10. Expression of dendritic cells in ovarian tumors correlates with clinical outcome in patients with ovarian cancer.
Eisenthal A; Polyvkin N; Bramante-Schreiber L; Misonznik F; Hassner A; Lifschitz-Mercer B
Hum Pathol; 2001 Aug; 32(8):803-7. PubMed ID: 11521223
[TBL] [Abstract][Full Text] [Related]
11. BTN3A2 expression in epithelial ovarian cancer is associated with higher tumor infiltrating T cells and a better prognosis.
Le Page C; Marineau A; Bonza PK; Rahimi K; Cyr L; Labouba I; Madore J; Delvoye N; Mes-Masson AM; Provencher DM; Cailhier JF
PLoS One; 2012; 7(6):e38541. PubMed ID: 22685580
[TBL] [Abstract][Full Text] [Related]
12. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
13. A novel nomogram based on LODDS to predict the prognosis of epithelial ovarian cancer.
Xu XL; Cheng H; Tang MS; Zhang HL; Wu RY; Yu Y; Li X; Wang XM; Mai J; Yang CL; Jiao L; Li ZL; Zhong ZM; Deng R; Li JD; Zhu XF
Oncotarget; 2017 Jan; 8(5):8120-8130. PubMed ID: 28042955
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of c-Abl predicts unfavorable outcome in epithelial ovarian cancer.
Zhou S; Tang L; Wang H; Dai J; Zhang J; Shen L; Ng SW; Berkowitz RS
Gynecol Oncol; 2013 Oct; 131(1):69-76. PubMed ID: 23820113
[TBL] [Abstract][Full Text] [Related]
15. Density of DC-LAMP(+) mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor.
Ladányi A; Kiss J; Somlai B; Gilde K; Fejos Z; Mohos A; Gaudi I; Tímár J
Cancer Immunol Immunother; 2007 Sep; 56(9):1459-69. PubMed ID: 17279413
[TBL] [Abstract][Full Text] [Related]
16. Tumor-infiltrating T cells in epithelial ovarian cancer: predictors of prognosis and biological basis of immunotherapy.
Wang W; Zou W; Liu JR
Gynecol Oncol; 2018 Oct; 151(1):1-3. PubMed ID: 30243508
[No Abstract] [Full Text] [Related]
17. [Tumor-infiltrating dendritic cells in epithelial ovarian carcinoma and correlation with the expression of vascular endothelial growth factor].
Mao YY; Chen HZ; Xie X; Ye DF; Lü WG
Zhonghua Fu Chan Ke Za Zhi; 2004 Oct; 39(10):693-7. PubMed ID: 16144569
[TBL] [Abstract][Full Text] [Related]
18. Significance of MNK1 in prognostic prediction and chemotherapy development of epithelial ovarian cancer.
Hou S; Du P; Wang P; Wang C; Liu P; Liu H
Clin Transl Oncol; 2017 Sep; 19(9):1107-1116. PubMed ID: 28332091
[TBL] [Abstract][Full Text] [Related]
19. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.
Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X
Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872
[TBL] [Abstract][Full Text] [Related]
20. T cell density and location can influence the prognosis of ovarian cancer.
Al-Attar A; Shehata M; Durrant L; Moseley P; Deen S; Chan S
Pathol Oncol Res; 2010 Sep; 16(3):361-70. PubMed ID: 20024633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]